Could Aravind Srinivas have achieved his full potential by remaining in India instead of moving to Silicon Valley? The ...

Vinay Prasad resigns from the FDA after backlash over vaccine restrictions and gene therapy decisions. Political pressure cited in sudden departure.

A controversial hematologist-oncologist who joined FDA this spring and quickly became its top regulator has left the ...

Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic ...

Vinay Prasad leaves FDA apparently due to backlash from the agency's handling of potential deaths related to Sarepta's ...

Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in ...

Sandvik unveils its 'Advancing to 2030' strategy, aiming to embed sustainability and digitalisation within its manufacturing ...

Vinay Prasad, a top official at the Food and Drug Administration, has suddenly departed after a series of controversial ...

In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed ...

Novo Nordisk (NYSE:NVO) announced on Tuesday that Maziar Mike Doustdar will become its new president and chief executive ...

Investing.com -- Novo Nordisk (NYSE: NVO) has appointed Maziar Mike Doustdar as its new president and chief executive officer ...

Novo Nordisk today announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective ...